Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe

BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) is increasingly recognized as a persistent disorder requiring long-term management. OBJECTIVES: Our objective was to evaluate the 2-year safety and efficacy of lisdexamfetamine dimesylate (LDX) in children and adolescents with ADHD. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Coghill, David R., Banaschewski, Tobias, Nagy, Peter, Otero, Isabel Hernández, Soutullo, César, Yan, Brian, Caballero, Beatriz, Zuddas, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511319/
https://www.ncbi.nlm.nih.gov/pubmed/28667569
http://dx.doi.org/10.1007/s40263-017-0443-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511319/
https://www.ncbi.nlm.nih.gov/pubmed/28667569
http://dx.doi.org/10.1007/s40263-017-0443-y

Ejemplares similares